Protocol No.: RTOG1216

Title
Randomized Phase II/III Trial of Adjuvant Radiation Therapy with Cisplatin, Docetaxel-Cetuximab, or Cisplatin-Atezolizumab in Pathologic High-Risk Squamous Cell Cancer of the Head and Neck
Principal Investigator
Almubarak, Mohammed
Phase
II/III (Cancer Control)
Age Group
Adult
Applicable Disease Site
Head and Neck Cancers
Participating Institutions
Camden Clark Medical Center
Mary Babb Randolph Cancer Center
Contacts
Nancy Delman, RN, OCN
Nurse
Heather Blatt, RN, OCN
Nurse
Nina Moore, RN
Research Specialist
Phone: +1 304-293-2991
Maher Kali, MD
Clinical Research Specialist-WVUCI
Phone: +1 304-243-7045
Layla Tannoury
Clinical Research Specialist
Phone: +1 304-424-2585

View on ClinicalTrials.gov